Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases

Area of Science:

• Immunology
• Dermatology
• Gastroenterology
• Rheumatology

Background:

• Anti-tumour necrosis factor (TNF)-α agents are widely used for inflammatory conditions.
• Biologic therapies are associated with a novel class of adverse events known as paradoxical reactions.
• The exact pathogenesis of paradoxical reactions remains elusive, but cytokine dysregulation is implicated.

Purpose of the Study:

• To analyze the clinical presentation and patient outcomes of autoimmune diseases induced by anti-TNF-α therapies.
• To provide insights into the mechanisms underlying these paradoxical reactions.

Main Methods:

• Review of clinical cases and literature on anti-TNF-α-induced autoimmune diseases.
• Dissection of clinical aspects and treatment outcomes.

Main Results:

• Identification of distinct clinical patterns of autoimmune diseases arising during anti-TNF-α treatment.
• Evaluation of the efficacy of various management strategies and their impact on patient outcomes.

Conclusions:

• Anti-TNF-α therapy can induce de novo autoimmune conditions.
• Understanding these paradoxical reactions is crucial for optimizing biologic therapy and patient management.